Xencor (XNCR) Return on Capital Employed Growth (3y) (2017 - 2026)
Xencor (XNCR) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 4,853.00 |
| 10 | Xencor | 1.50 Bn | 1.11 Bn | - | -662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -662.00 |
| Dec 31, 2025 | -1,225.00 |
| Sep 30, 2025 | -2,427.00 |
| Jun 30, 2025 | -2,444.00 |
| Mar 31, 2025 | -3,079.00 |
| Dec 31, 2024 | -2,636.00 |
| Sep 30, 2024 | -1,377.00 |
| Jun 30, 2024 | -1,392.00 |
| Mar 31, 2024 | -69.00 |
| Dec 31, 2023 | -272.00 |
| Sep 30, 2023 | -406.00 |
| Jun 30, 2023 | -700.00 |
| Mar 31, 2023 | -1,019.00 |
| Dec 31, 2022 | -1,288.00 |
| Sep 30, 2022 | 312.00 |
| Jun 30, 2022 | 16.00 |
| Mar 31, 2022 | 567.00 |
| Dec 31, 2021 | 2,133.00 |
| Sep 30, 2021 | 43.00 |
| Jun 30, 2021 | 884.00 |